Other
Therapeutic drug monitoring (TDM)
Therapeutic drug monitoring (TDM) is an intervention with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_3
1
25%
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
unknown1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (25.0%)
N/A3 (75.0%)
Trials by Status
unknown125%
completed250%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
terminatednot_applicable
Proactive Therapeutic Drug Monitoring Based Adalimumab Therapy Optimization in Patients With Rheumatoid Arthritis
NCT05460390
unknownnot_applicable
Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections
NCT05942157
completednot_applicable
Saliva and Dried Blood Spot Therapeutic Drug Monitoring for MDR-TB in Tanzania
NCT04124055
completedphase_3
Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor
NCT00041769
Clinical Trials (4)
Showing 4 of 4 trials
NCT05460390Not Applicable
Proactive Therapeutic Drug Monitoring Based Adalimumab Therapy Optimization in Patients With Rheumatoid Arthritis
NCT05942157Not Applicable
Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections
NCT04124055Not Applicable
Saliva and Dried Blood Spot Therapeutic Drug Monitoring for MDR-TB in Tanzania
NCT00041769Phase 3
Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4